Allostatic Load in Patients with Type 2 Diabetes Treated with GLP-1 Receptor Agonists

GLP-1 treatment was not associated with lower allostatic load compared with other treatment regimens in patients with T2DM. Longitudinal studies with neuroendocrine measures are needed to better characterize its effects on stress regulation.

Authors

Institutions

Publication Details

Journal
Metabolic Syndrome and Related Disorders
Published
2026-03-14
DOI
https://doi.org/10.1177/15578518261431688
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Allostatic Load in Patients with Type 2 Diabetes Treated with GLP-1 Receptor Agonists

Yang Yu, Susan Groth
Metabolic Syndrome and Related Disorders
Diabetes Treatment and Management
article

Allostatic Load in Patients with Type 2 Diabetes Treated with GLP-1 Receptor Agonists

Yang Yu, Susan Groth
article en

Abstract

GLP-1 treatment was not associated with lower allostatic load compared with other treatment regimens in patients with T2DM. Longitudinal studies with neuroendocrine measures are needed to better characterize its effects on stress regulation.

Metabolic Syndrome and Related Disorders
University of Rochester (US)
Zero hunger
Openalex Percentile: Top 23%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.